Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03421288 |
|---|---|
| Brief Title: | Phase II Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (DANTE) |
| First Submitted : | January 11, 2018 |
| First Submitted that Met QC Criteria : | January 29, 2018 |
| First Posted : | February 5, 2018 |
| Last Update Submitted that Met QC Criteria : | April 14, 2022 |
| Last Update Posted : | April 15, 2022 |